ArticleACS omega2026
The Role of TRPV1 Channel in Cosmetic Safety Evaluation.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Irritation is one of the most concerning aspects for both customs and the industry. In recent years, the transient receptor potential vanilloid type 1 (TRPV1) channel has raised great attention worldwide and is characterized as one of the most well-known pain-inducing receptors nowadays. This study focuses on the relationship between the sense of sting raised by surfactants and the TRPV1 channel. Twenty-six surfactants commonly used in the cosmetic industry were tested on both native HaCaT cells and stable TRPV1-overexpressing HaCaT cells for assessing their ability to cause Ca
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.